Shree Pacetronix (SHREEPAC) | Stock Overview & Key Data
Shree Pacetronix Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹391.90 on November 6, 2023
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shree Pacetronix
SHREEPAC
|
532.08M Small-cap | -0.39% | 4.04% | 31.20% | -46.19% | -22.04% | 73.55% | -37.38% | 1,403.82% | 743.43% | 289.00% | 1,913.14% |
|
Poly Medicure
POLYMED
|
151.00B Mid-cap | 9.26% | 0.80% | 20.33% | -19.36% | -13.29% | -31.00% | 33.68% | 70.32% | 703.44% | 4,602.06% | 4,602.06% |
|
Dr Agarwal's Health
AGARWALEYE
|
138.86B Mid-cap | -2.72% | -2.40% | 3.65% | -11.79% | -12.18% | 17.19% | 9.38% | 9.38% | 9.38% | 9.38% | 9.38% |
|
Tarsons Products
TARSONS
|
11.01B Small-cap | -0.12% | -0.11% | 8.87% | -10.58% | -11.95% | -47.38% | -64.08% | -74.91% | -74.91% | -74.91% | -74.91% |
|
Laxmi Dental
LAXMIDENTL
|
10.40B Small-cap | 1.49% | 12.83% | 31.31% | -15.20% | -17.46% | -47.17% | -55.90% | -55.90% | -55.90% | -55.90% | -55.90% |
|
Prevest Denpro
PREVEST
|
5.42B Small-cap | -0.84% | -5.49% | -5.28% | -20.44% | -18.59% | -20.44% | -9.34% | 356.55% | 356.55% | 356.55% | 356.55% |
Ownership & Short Interest
Calculate Your Shree Pacetronix Investment Returns
Long-Term Investment Performance Analysis
Shree Pacetronix stock price in Jul 2016 was ₹16.00, A ₹1,000.00 lump sum investment in Shree Pacetronix made 9 years ago would be worth approximately ₹8,843.75 today, representing a exceptional return of 784.38%. This translates to an annualized return (CAGR) of 24.61%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is SHREEPAC's 52-week high and low?
- In the last 52 weeks, Shree Pacetronix reached a high of ₹283.15 (on October 28, 2025) and a low of ₹66.10 (on June 26, 2025).
- What is the market cap and P/E ratio for SHREEPAC?
- Curious about Shree Pacetronix's size and valuation? Its market capitalization stands at 532.08M. When it comes to valuation, the P/E ratio (trailing twelve months) is 20.75, and the forward P/E (looking ahead) is N/A.
- Does SHREEPAC pay dividends? If so, what's the yield?
- As for dividends, Shree Pacetronix isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Shree Pacetronix's main competitors or similar companies to consider before investing?
When looking at Shree Pacetronix, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Poly Medicure
POLYMED151.00B Healthcare Medical Instruments & Supplies -31.00% 33.68% Dr Agarwal's Health
AGARWALEYE138.86B Healthcare Medical Instruments & Supplies 17.19% 9.38% Tarsons Products
TARSONS11.01B Healthcare Medical Instruments & Supplies -47.38% -64.08% Laxmi Dental
LAXMIDENTL10.40B Healthcare Medical Instruments & Supplies -47.17% -55.90% Prevest Denpro
PREVEST5.42B Healthcare Medical Instruments & Supplies -20.44% -9.34% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Shree Pacetronix Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Shree Pacetronix's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.44%, the Debt to Equity ratio from the most recent quarter is 32.04, and its Gross Profit Margin stands at 69.97%.
- What is the recent revenue and earnings growth for SHREEPAC?
- Looking at Shree Pacetronix's growth, its revenue over the trailing twelve months (TTM) was INR205M. Compared to the same quarter last year (YoY), quarterly revenue grew by 19.60%, and quarterly earnings saw a YoY growth of 19.57%.
- How much of SHREEPAC stock is held by insiders and institutions?
- Wondering who owns Shree Pacetronix stock? Company insiders (like executives and directors) hold about 66.74% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.